Literature DB >> 9644076

New ceramide from marine sponge Haliclona koremella and related compounds as antifouling substances against macroalgae.

T Hattori1, K Adachi, Y Shizuri.   

Abstract

A new ceramide N-docosanoyl-d-erythro-(2S, 3R)-16-methyl-heptadecasphing-4(E)-enine (C22 ceramide) was isolated from the marine sponge Haliclona koremella as an antifouling substance against macroalgae. The structure of this substance was elucidated by spectral means. Antifouling activity of several related compounds was also examined.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9644076     DOI: 10.1021/np970527y

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  5 in total

1.  Antiepileptic ceramides from the Red Sea sponge Negombata corticata.

Authors:  Safwat A Ahmed; Sherief I Khalifa; Mark T Hamann
Journal:  J Nat Prod       Date:  2008-03-21       Impact factor: 4.050

2.  Activity of Haliscosamine against Fusarium oxysporum f.sp. melonis: in vitro and in vivo analysis.

Authors:  Belakssem El Amraoui; Jean François Biard; Fatima Ez-Zohra Ikbal; Majida El Wahidi; Mostafa Kandil; Mohammed El Amraoui; Aziz Fassouane
Journal:  Springerplus       Date:  2015-01-13

Review 3.  Marine sponges as pharmacy.

Authors:  Detmer Sipkema; Maurice C R Franssen; Ronald Osinga; Johannes Tramper; René H Wijffels
Journal:  Mar Biotechnol (NY)       Date:  2005-03-24       Impact factor: 3.619

4.  Biomimetic Approaches for the Development of New Antifouling Solutions: Study of Incorporation of Macroalgae and Sponge Extracts for the Development of New Environmentally-Friendly Coatings.

Authors:  Ilse Sánchez-Lozano; Claudia Judith Hernández-Guerrero; Mauricio Muñoz-Ochoa; Claire Hellio
Journal:  Int J Mol Sci       Date:  2019-09-30       Impact factor: 5.923

5.  Neritinaceramides A-E, new ceramides from the marine bryozoan Bugula neritina inhabiting South China Sea and their cytotoxicity.

Authors:  Xiang-Rong Tian; Hai-Feng Tang; Jun-Tao Feng; Yu-Shan Li; Hou-Wen Lin; Xiao-Pei Fan; Xing Zhang
Journal:  Mar Drugs       Date:  2014-04-02       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.